Patent · US Active

Epidermal growth factor receptor gene copy number

US7635570B2 · kind B2 · utility

10Cited by

0References

19Claims

0Family size

Inventors

Salvatore Siena · Milano, IT
Mauro Moroni · Milano, IT
Alberto Bardelli · Baltimore, US

Key dates

Filing date	Mar 30, 2006
Grant date	Dec 22, 2009
Priority date	—
Expiry date	Jun 28, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/156
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Methods of predicting whether an anti-epidermal growth factor receptor (“EGFr”)-specific binding agent treatment will be efficacious in treating cancer, and methods of treating patients with anti-EGFr-specific binding agents, are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.